Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Safety of repeat intravitreal injections of bevacizu-mab versus ranibizumab: our experience after 2,000 injections.Retina. 2009; 29: 313-318
- Infectious endophthalmitis after intravitreal injection of antiangiogenic agents.Retina. 2009; 29: 601-605
- Persisent ocular hypertension following intravitreal ranibizumab.Graefes Arch Clin Exp Ophthalmol. 2008; 246: 955-958
- Clinical safety of ranibizumab in age-related macular degeneration.Expert Opin Drug Saf. 2010; 9: 149-165
- Identifying systemic safety signals following intravitreal bevacizumab: systematic reviewof the literature and the Canadian Adverse Drug Reaction Database.Can J Ophthalmol. 2010; 45: 231-238
- Early loss of pregnancy after intravitreal bevacizumab injection.Acta Ophthalmol. 2009; ([Epub ahead of print])
- Relationship between age-related macular degeneration-associated variants of complement factor H and LOC387715 with coronary artery disease.Mayo Clin Proc. 2007; 82: 301-307
- Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study.Ophthalmology. 2009; 116: 1913-1919
- Inadvertent use of bevacizumab to treat choroidal neovascularisation during pregnancy: a case report.Ann Acad Med Singapore. 2010; 39: 143-145
- The effect of intravi-treal bevacizumab in the treatment ofCoats disease in children.Retina. 2010; 30: 617-622
- A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity.Am J Ophthalmol. 2009; 148: 536-543.e2
- Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study.J ClinOncol. 2008; 26: 399-405
*Supported in part by an unrestricted grant from Research to Prevent Blindness Inc, N.Y.